Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Clinical trial NCT07750951 · RECRUITING
Trial details
- NCT number
- NCT07750951
- Sponsor
- Xijing Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2026-11-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.